FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT

U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech's COVID-19 vaccine for children aged 5 to 11 as soon as Tuesday, the New York Times reported on Monday, citing people familiar with the matter. The companies submitted an application to the U.S. Food and Drug Administration for the authorization last month. They have cited data from a mid- to late-stage study showing a third dose of their shot increased protection against the original coronavirus version and the Omicron variant among children in the age group.